Skip to main navigation Skip to search Skip to main content

Absolute Bioavailability of Intranasal HCl in Patients with Rhinitis and Rhinitis Treated with Oxymetazoline (HM9905)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/002/28/02

Funding

  • Inhalation Technology Inc: $75,552.00